AdvisorShares Psychedelics Valuation
| PSIL Etf | USD 17.54 0.50 2.93% |
At this time, the entity appears to be overvalued. AdvisorShares Psychedelics shows a prevailing Real Value of $15.72 per share. The current price of the entity is $17.54. Our model approximates the value of AdvisorShares Psychedelics from analyzing the entity fundamentals such as net asset of 7.74 M, and Beta of 0.59 as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that AdvisorShares Psychedelics' price fluctuation is not too volatile at this time. Calculation of the real value of AdvisorShares Psychedelics is based on 3 months time horizon. Increasing AdvisorShares Psychedelics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the AdvisorShares etf is determined by what a typical buyer is willing to pay for full or partial control of AdvisorShares Psychedelics ETF. Since AdvisorShares Psychedelics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of AdvisorShares Etf. However, AdvisorShares Psychedelics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 17.54 | Real 15.72 | Hype 17.63 |
The intrinsic value of AdvisorShares Psychedelics' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence AdvisorShares Psychedelics' stock price.
Estimating the potential upside or downside of AdvisorShares Psychedelics ETF helps investors to forecast how AdvisorShares etf's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of AdvisorShares Psychedelics more accurately as focusing exclusively on AdvisorShares Psychedelics' fundamentals will not take into account other important factors: About AdvisorShares Psychedelics Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of AdvisorShares Psychedelics ETF. In general, an absolute valuation paradigm, as applied to this etf, attempts to find the value of AdvisorShares Psychedelics based exclusively on its fundamental and basic technical indicators. By analyzing AdvisorShares Psychedelics's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of AdvisorShares Psychedelics's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of AdvisorShares Psychedelics. We calculate exposure to AdvisorShares Psychedelics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of AdvisorShares Psychedelics's related companies.The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80 percent of its net assets in securities of companies that derive at least 50 percent of their net revenue from or devote 50 percent of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. Advisorshares Psychedelics is traded on NYSEARCA Exchange in the United States.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in AdvisorShares Psychedelics ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
The market value of AdvisorShares Psychedelics is measured differently than its book value, which is the value of AdvisorShares that is recorded on the company's balance sheet. Investors also form their own opinion of AdvisorShares Psychedelics' value that differs from its market value or its book value, called intrinsic value, which is AdvisorShares Psychedelics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AdvisorShares Psychedelics' market value can be influenced by many factors that don't directly affect AdvisorShares Psychedelics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between AdvisorShares Psychedelics' value and its price as these two are different measures arrived at by different means. Investors typically determine if AdvisorShares Psychedelics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AdvisorShares Psychedelics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.